Helius Medical Technologies has rebranded as Solana Company following board approval, while retaining its NASDAQ stock symbol HSDT. The company has signed a non-binding letter of intent with the Solana Foundation, committing to conduct all on-chain activities exclusively on the Solana blockchain. This partnership includes co-hosting events and forming institutional partnerships. As part of the agreement, Solana Company will have the opportunity to purchase Solana tokens at a discount, contingent upon meeting specific conditions. The company plans to leverage its recent $500 million PIPE financing to accumulate Solana tokens, aligning with its digital asset treasury strategy to generate on-chain revenue.